Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH): A systematic review and meta-analysis
Medicine;105(43):e51306
Efficacy and safety of GLP-1 receptor agonists for antipsychotic-related overweight and metabolic dysregulation: a systematic review and meta-analysis
European journal of clinical pharmacology, 2026;82(11)
GLP-1 receptor agonists for obstructive sleep apnea: a meta-analysis of randomized controlled trials
Sleep & breathing = Schlaf & Atmung, 2026;30(5)
CagriSema versus Semaglutide 2.4 mg monotherapy for weight management in adults with overweight or obesity, with or without type 2 diabetes: a systematic review, meta-analysis, and trial sequential analysis
Frontiers in endocrinology, 2026;17:1903335
Weight Reduction Heterogenicity and Mediators of GLP-1RAs and Dual Agonists for Individuals With Obesity: A Meta-Analysis
Clinical obesity;16(5):e70112
Efficacy and Safety of Tirzepatide Versus Dulaglutide in Type 2 Diabetes With or Without Established Atherosclerotic Cardiovascular Disease: A Network Meta-Analysis of Randomized Clinical Trials
Endocrinology, diabetes & metabolism;9(5):e70313
Weight regain following discontinuation of glucagon-like peptide-1 receptor agonists in adults who are overweight or obese: a systematic review and meta-analysis
PeerJ, 2026;14:e21713
Comparative Efficacy of Tirzepatide Versus Semaglutide for Weight Loss in Adults With Overweight or Obesity: A Systematic Review and Meta-Analysis of Head-to-Head Studies
Clinical obesity;16(5):e70111
Weight Regain Trajectories After Discontinuation of Semaglutide or Tirzepatide: A Reconstructed Aggregate-Data Bayesian Longitudinal Meta-Analysis
Endocrinology, diabetes & metabolism;9(5):e70325
Use of incretin receptor agonists in patients submitted to metabolic bariatric surgery – a systematic review and meta-analysis
Frontiers in endocrinology, 2026;17:1870008
Semaglutide-Induced Nonarteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis
Journal of clinical pharmacology;66(8):e70248
Effect of tirzepatide and semaglutide on blood pressure: A systematic review and meta-analysis
Endocrine, 2026;91(1)
Burden and Risk of Depression in Patients Receiving Semaglutide: A Systematic Review and Meta-Analysis
Clinical obesity;16(5):e70105
Effectiveness & safety of semaglutide in weight reduction in obese nondiabetic patients: A systematic review and meta-analysis
Medicine;105(31):e49986
Hypertensive disorders of pregnancy and GLP-1 receptor agonist timing: a systematic review and meta-analysis
Endocrine, 2026;91(1)
Therapeutic role of semaglutide in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis of placebo-controlled trials with GRADE evidence assessment
Medicine;105(30):e49916
Comparative Efficacy and Safety of Tirzepatide in Asian and Non-Asian Adults With Obesity Without Diabetes: A Systematic Review and Meta-Analysis
Endocrinology, diabetes & metabolism;9(4):e70291
Effect of glucagon-like peptide-1 receptor agonists on body weight and urinary albumin-to-creatinine ratio in patients with and without type 2 diabetes: A systematic review and meta-analysis
The Journal of international medical research, 2026;54(7):3000605261458641
Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis
BMJ (Clinical research ed.), 2026;394:e372161
Long-term effects of weight-reducing drugs in people with hypertension
The Cochrane database of systematic reviews, 2026;6:CD007654